Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants

Pharmacoepidemiology and Drug Safety
Deborah ShatinDavid Graham

Abstract

An evaluation was made of the effectiveness in changing prescribing behavior of 'Dear Health Professional (DHP)' letters mailed by the manufacturer to physicians and other health professionals advising them of safety information on co-prescribing of tramadol and antidepressants. A retrospective cohort analysis of prescription claims of all plan members from 12 UnitedHealth Group-affiliated health plans who received a first prescription for tramadol between 1 April 1995 and 31 December 1996. The prevalence of co-prescribing of antidepressants and tramadol relative to the date of the 'DHP' communication was determined. 9218 plan members received an initial prescription for tramadol within the observation period. Prior to the date of the 'DHP' communication 1061/4774 (22.2%) members received a prescription for an antidepressant within 30 days of their first prescription for tramadol. Following the date of the communication 844/4444 (19.0%) of members received an antidepressant within 30 days of their first prescription for tramadol. An overall decreasing linear trend in antidepressant co-prescribing was evident over the observation period, but there was no statistically significant acceleration in the decrease following this commu...Continue Reading

References

Dec 1, 1987·American Journal of Public Health·S B SoumeraiS Hawley
May 1, 1996·JAMA : the Journal of the American Medical Association·D Thompson, G Oster
Jul 25, 1996·The New England Journal of Medicine·D K Wysowski, J Bacsanyi
Dec 5, 1997·JAMA : the Journal of the American Medical Association·L H KahnD J Graham
May 30, 1998·JAMA : the Journal of the American Medical Association·T J MooreC D Furberg
Dec 21, 2000·JAMA : the Journal of the American Medical Association·W SmalleyW A Ray
Dec 21, 2000·JAMA : the Journal of the American Medical Association·R L Woosley
Dec 29, 2000·Pharmacotherapy·J S GardnerR Alderfer
Oct 5, 2001·JAMA : the Journal of the American Medical Association·J K JonesM Shannon
Jul 11, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Mary E WillyDavid J Graham

❮ Previous
Next ❯

Citations

May 21, 2011·European Journal of Clinical Pharmacology·Hélène ThéophileFrançoise Haramburu
Apr 28, 2007·The Australian and New Zealand Journal of Psychiatry·Elizabeth E RougheadAndrew L Gilbert
Aug 30, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Elmira ValiyevaGeoffrey M Anderson
Sep 27, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Keith B HoffmanColin B Erdman
Jun 16, 2006·Expert Opinion on Drug Safety·Bruce Hugman, I Ralph Edwards
Oct 9, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Gabriel Sanfélix-GimenoTeresa Barbera
Apr 7, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sigrid PieningPeter G M Mol
May 11, 2015·Research in Social & Administrative Pharmacy : RSAP·Manish MittalYu-Tze Ng
Mar 18, 2008·Oral and Maxillofacial Surgery Clinics of North America·Elliot V HershAndres Pinto
Apr 17, 2007·Pharmacoepidemiology and Drug Safety·Angela J DeanTreasure McGuire
Mar 13, 2014·Pharmacoepidemiology and Drug Safety·Inna GridchynaYola Moride
Sep 2, 2005·Pharmacoepidemiology and Drug Safety·Deborah ShatinKenneth G Saag
Aug 11, 2015·Clinical Therapeutics·Sara SoaresMaria Teresa Herdeiro
Jun 5, 2016·Fundamental & Clinical Pharmacology·Maria T HerdeiroAdolfo Figueiras
Oct 25, 2013·Journal of Pharmacy Practice·Susie H ParkGlen L Stimmel
Dec 15, 2010·Multiple Sclerosis : Clinical and Laboratory Research·S ChanH Tremlett
Nov 7, 2017·British Journal of Clinical Pharmacology·Thomas GoedeckeXavier Kurz
Feb 12, 2020·Pharmacoepidemiology and Drug Safety·Ulrike GeorgiStefanie Deckert
Jan 1, 2013·ISRN Pain·Chiara AngelettiGiustino Varrassi
Oct 27, 2021·Clinical Pharmacology and Therapeutics·Gerald J Dal Pan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.